Stuttgart - Delayed Quote EUR

Nucana PLC (ADRs) (N04.SG)

0.0440
-0.0365
(-45.34%)
At close: May 9 at 3:18:56 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
23,005
23,005
31,125
43,717
45,363
Operating Income
-23,005
-23,005
-31,125
-43,717
-45,363
Net Non Operating Interest Income Expense
358
358
754
669
103
Other Income Expense
196
196
-1,659
4,595
-2,542
Pretax Income
-22,451
-22,451
-32,030
-38,453
-47,802
Tax Provision
-3,454
-3,454
-4,398
-6,432
-7,269
Net Income Common Stockholders
-18,997
-18,997
-27,632
-32,021
-40,533
Diluted NI Available to Com Stockholders
-18,997
-18,997
-27,632
-32,021
-40,533
Basic EPS
-6.50
--
-13.25
-15.25
-19.50
Diluted EPS
-6.50
--
-13.25
-15.25
-19.50
Basic Average Shares
2,967.6400
--
2,102.9200
2,089.4000
2,078.6150
Diluted Average Shares
2,967.6400
--
2,102.9200
2,089.4000
2,078.6150
Total Operating Income as Reported
-22,809
-22,809
-32,784
-39,122
-47,905
Total Expenses
23,005
23,005
31,125
43,717
45,363
Net Income from Continuing & Discontinued Operation
-18,997
-18,997
-27,632
-32,021
-40,533
Normalized Income
-19,162.8462
-19,162.8462
-26,200.7953
-35,847.3983
-38,377.5486
Interest Income
358
358
754
669
103
Net Interest Income
358
358
754
669
103
EBIT
-23,005
-23,005
-31,125
-43,717
-45,363
EBITDA
-22,483
-22,483
-30,550
-42,985
-44,421
Reconciled Depreciation
522
522
575
732
942
Net Income from Continuing Operation Net Minority Interest
-18,997
-18,997
-27,632
-32,021
-40,533
Total Unusual Items Excluding Goodwill
196
196
-1,659
4,595
-2,542
Total Unusual Items
196
196
-1,659
4,595
-2,542
Normalized EBITDA
-22,679
-22,679
-28,891
-47,580
-41,879
Tax Rate for Calcs
0.0002
0.0002
0.0001
0.0002
0.0002
Tax Effect of Unusual Items
30.1538
30.1538
-227.7953
768.6017
-386.5486
12/31/2021 - 1/14/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

226950.KQ OliX Pharmaceuticals, Inc
43,000.00
-1.15%
 
HEMO.L Hemogenyx Pharmaceuticals Plc
181.50
-0.82%
 
POLB.L Poolbeg Pharma PLC
2.8000
-5.08%
 
TSBX Turnstone Biologics Corp.
0.3399
+2.13%
 
NRX.V NurExone Biologic Inc.
0.6600
-2.94%
 
ALNEV.PA Neovacs S.A.
0.0100
-23.66%
 
HOPHF Hemogenyx Pharmaceuticals Plc
0.0400
0.00%
 
TNFA TNF Pharmaceuticals, Inc.
0.1900
-3.36%
 
CLRB Cellectar Biosciences, Inc.
0.2474
-1.63%
 
PRQR ProQR Therapeutics N.V.
1.6100
+3.87%